Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Bezdekova R, Jelinek T, Kralova R, Stork M, Polackova P, Vsianska P, Brozova L, Jarkovsky J, Almasi M, Boichuk I, Knechtova Z, Penka M, Pour L, Sevcikova S, Hajek R, Rihova L. Bezdekova R, et al. Among authors: brozova l. Br J Haematol. 2021 Oct;195(1):95-107. doi: 10.1111/bjh.17713. Epub 2021 Sep 9. Br J Haematol. 2021. PMID: 34500493 Free PMC article.
Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.
Sedlarikova L, Gromesova B, Kubaczkova V, Radova L, Filipova J, Jarkovsky J, Brozova L, Velichova R, Almasi M, Penka M, Bezdekova R, Stork M, Adam Z, Pour L, Krejci M, Kuglík P, Hajek R, Sevcikova S. Sedlarikova L, et al. Among authors: brozova l. Eur J Haematol. 2017 Sep;99(3):223-233. doi: 10.1111/ejh.12908. Epub 2017 Jun 29. Eur J Haematol. 2017. PMID: 28543758
Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients.
Vrabel D, Sedlarikova L, Besse L, Rihova L, Bezdekova R, Almasi M, Kubaczkova V, Brožová L, Jarkovsky J, Plonkova H, Jelinek T, Sandecka V, Stork M, Pour L, Sevcikova S, Hajek R. Vrabel D, et al. Among authors: brozova l. Eur J Haematol. 2020 Mar;104(3):190-197. doi: 10.1111/ejh.13358. Epub 2019 Dec 20. Eur J Haematol. 2020. PMID: 31763708 Free PMC article.
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
Stork M, Sevcikova S, Minarik J, Krhovska P, Radocha J, Pospisilova L, Brozova L, Jarkovsky J, Spicka I, Straub J, Pavlicek P, Jungova A, Jelinek T, Sandecka V, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: brozova l. Br J Haematol. 2022 Feb;196(4):954-962. doi: 10.1111/bjh.17925. Epub 2021 Nov 2. Br J Haematol. 2022. PMID: 34726261 Free PMC article.
Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia.
Kryukov F, Dementyeva E, Kubiczkova L, Jarkovsky J, Brozova L, Petrik J, Nemec P, Sevcikova S, Minarik J, Stefanikova Z, Kuglik P, Hajek R. Kryukov F, et al. Among authors: brozova l. Genomics. 2013 Oct;102(4):243-9. doi: 10.1016/j.ygeno.2013.06.007. Epub 2013 Jul 3. Genomics. 2013. PMID: 23831116 Free article.
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
Sandecká V, Hájek R, Pour L, Špička I, Ščudla V, Gregora E, Radocha J, Walterová L, Kessler P, Zahradová L, Adamová D, Valentova K, Vonke I, Obernauerová J, Starostka D, Wróbel M, Brožová L, Jarkovský J, Mikulášová A, Říhová L, Ševčíková S, Straub J, Minařík J, Adam Z, Krejčí M, Král Z, Maisnar V; Czech Myeloma Group. Sandecká V, et al. Among authors: brozova l. Eur J Haematol. 2017 Jul;99(1):80-90. doi: 10.1111/ejh.12894. Epub 2017 May 11. Eur J Haematol. 2017. PMID: 28384387
Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies.
Sedlarikova L, Bollova B, Radova L, Brozova L, Jarkovsky J, Almasi M, Penka M, Kuglík P, Sandecká V, Stork M, Pour L, Sevcikova S. Sedlarikova L, et al. Among authors: brozova l. Hematol Oncol. 2018 Dec;36(5):786-791. doi: 10.1002/hon.2554. Epub 2018 Sep 13. Hematol Oncol. 2018. PMID: 30144133 Free PMC article. Clinical Trial.
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model.
Hájek R, Sandecka V, Špička I, Raab M, Goldschmidt H, Beck S, Minařík J, Pavlíček P, Radocha J, Heindorfer A, Jelínek T, Stejskal L, Brožová L, Ševčíková S, Straub J, Pika T, Pour L, Maisnar V, Seckinger A, Hose D. Hájek R, et al. Among authors: brozova l. Br J Haematol. 2020 Jul;190(2):189-197. doi: 10.1111/bjh.16572. Epub 2020 Mar 12. Br J Haematol. 2020. PMID: 32163180 Free article.
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Sandecká V, Pour L, Špička I, Minařík J, Radocha J, Jelínek T, Heindorfer A, Pavlíček P, Sýkora M, Jungová A, Kessler P, Wróbel M, Starostka D, Ullrychová J, Stejskal L, Štork M, Straub J, Pika T, Brožová L, Ševčíková S, Maisnar V, Hájek R. Sandecká V, et al. Among authors: brozova l. Eur J Haematol. 2021 Oct;107(4):466-474. doi: 10.1111/ejh.13683. Epub 2021 Jul 28. Eur J Haematol. 2021. PMID: 34272773
42 results